a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
Published 1 year ago • 129 plays • Length 1:37Download video MP4
Download video MP3
Similar videos
-
2:36
phase ii study of e7820 in patients with splicing factor-mutant myeloid malignancies
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
2:13
splicing mutations in post-et/post-pv myelofibrosis
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
7:42
phase ii trial of bomedemstat for advanced myelofibrosis
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
1:25
the current approach to managing patients with prefibrotic pmf
-
15:57
aggregasi trombosit menggunakan alat aggram by helena laboratories
-
32:56
echo analyzer monthly maintenance
-
3:35
epigenomics in precision oncology
-
2:00
update of a phase i trial investigating lintuzumab-ac225 plus venetoclax in r/r aml
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
14:38
hematology in 10 min hemostasis and coagulation mp4 final
-
0:53
go-flag: bridge therapy to allo-sct in r/r aml
-
3:07
ibrutinib venetoclax in treatment-naïve wm: results from a phase ii trial
-
2:02
phase ii animate trial investigating pet response-adapted treatment using nivolumab in r/r chl
-
2:13
haploidentical sct for the treatment of secondary aml
-
4:44
7-year update on a phase ii trial of fixed-duration obinutuzumab, ibrutinib, and venetoclax for cll
-
3:46
the impact of cytogenetic risk on outcomes of haploidentical transplantation in r/r aml
-
3:10
novel aml treament approaches